An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	1998

Gelijkaardige items

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
door: Cerundolo, V, et al.
Gepubliceerd in: (1998)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
door: Kelleher, A, et al.
Gepubliceerd in: (2001)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
door: Gileadi, U, et al.
Gepubliceerd in: (1999)

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
door: Klenerman, P, et al.
Gepubliceerd in: (1998)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
door: Anjali K. Gupta, et al.
Gepubliceerd in: (2007-04-01)

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
door: Milicic, A, et al.
Gepubliceerd in: (2005)

Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
door: Atul Pawar, et al.
Gepubliceerd in: (2020-01-01)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
door: Valmori, D, et al.
Gepubliceerd in: (1999)

Computational investigations of HIV-1 protease and protease inhibitors interactions
door: Sham, Hoi Fung
Gepubliceerd in: (2014)

The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
door: Cerundolo, V, et al.
Gepubliceerd in: (1997)

Current and Novel Inhibitors of HIV Protease
door: Jan Konvalinka, et al.
Gepubliceerd in: (2009-12-01)

Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
door: Johanna Bialas, et al.
Gepubliceerd in: (2015-01-01)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
door: Kourjian G, et al.
Gepubliceerd in: (2012-09-01)

Additivity in the Analysis and Design of HIV Protease Inhibitors
door: Jorissen, Robert N., et al.
Gepubliceerd in: (2012)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
door: V.B. Denisenko, et al.
Gepubliceerd in: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
door: V.B. Denisenko, et al.
Gepubliceerd in: (2010-02-01)

Proteasome inhibitors as anti-cancer agents.
door: Murray, R, et al.
Gepubliceerd in: (2000)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
door: Valmori, D, et al.
Gepubliceerd in: (1999)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
door: Gupta, A, et al.
Gepubliceerd in: (2005)

Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
door: Larissa da Costa Souza, et al.
Gepubliceerd in: (2014-01-01)

New proteasome inhibitors in the management of multiple myeloma
door: S. V. Semochkin
Gepubliceerd in: (2019-07-01)

MAPPING OF PATENTS RELATED TO PROTEASE INHIBITORS AND HIV
door: Romério Rodrigues dos Santos Silva, et al.
Gepubliceerd in: (2022-04-01)

Role of Gag in HIV Resistance to Protease Inhibitors
door: Fabrizio Mammano, et al.
Gepubliceerd in: (2010-07-01)

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
door: Roberta Rinaldi, et al.
Gepubliceerd in: (2021-11-01)

TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
door: Abhilash I. Chiramel, et al.
Gepubliceerd in: (2019-06-01)

Site-Specific Proteasome Inhibitors
door: Alexei F. Kisselev
Gepubliceerd in: (2021-12-01)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
door: Noah M. Merin, et al.
Gepubliceerd in: (2014-12-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
door: Christoph Driessen, et al.
Gepubliceerd in: (2016-03-01)

Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.
door: Hemelaar, J, et al.
Gepubliceerd in: (2001)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
door: Nathalie Vigneron, et al.
Gepubliceerd in: (2015-09-01)

Evaluation of COVID-19 protease and HIV inhibitors interactions
door: Tran Linh, et al.
Gepubliceerd in: (2022-03-01)

Safety of protease inhibitors in HIV-infected pregnant women
door: Chougrani I, et al.
Gepubliceerd in: (2013-09-01)

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
door: Kathleen M S E Reyskens, et al.
Gepubliceerd in: (2013-01-01)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
door: Konvalinka Jan, et al.
Gepubliceerd in: (2011-08-01)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
door: Kann G, et al.
Gepubliceerd in: (2021-08-01)

Immune surveillance and AIDS progression.
door: Zinkernagel, R, et al.
Gepubliceerd in: (1997)

Correspondence - Immune surveillance and AIDS progression
door: Zinkernagel, R, et al.
Gepubliceerd in: (1997)

Of mice and men: cytotoxic T cells and AIDS pathogenesis.
door: Klenerman, P, et al.
Gepubliceerd in: (1999)

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
door: Klenerman, P, et al.
Gepubliceerd in: (1997)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
door: J. Lopes, et al.
Gepubliceerd in: (2021-04-01)